EGFR and metabolic dysfunction-associated steatotic liver disease: In this study, we found that the NAFLD hepatic metabolic microenvironment could also enhance de novo palmitate biosynthesis in liver metastatic CRC cells and that enriched intracellular palmitate bioavailability could promote cancer cell stemness by facilitating palmitoylation of EGFR to promote its stability and PM localization.